AHL
GH icon

Abel Hall LLC’s Guardant Health GH Stock Holding History

Abel Hall LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
7,960
+3,409
+75% +$371K 0.21% 63
2026
Q1 		$420K Buy
4,551
+18
+0.4% +$1.81K 0.09% 255
2025
Q4 		$463K Buy
4,533
+751
+20% +$67.2K 0.11% 192
2025
Q3 		$236K Sell
3,782
-100
-3% -$5.44K 0.1% 231
2025
Q2 		$202K Buy
+3,882
New +$173K 0.09% 232

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Abel Hall LLC's GH Position: Q2 2026 in Review

Abel Hall LLC increased its Guardant Health (GH) stake by 75% in Q2 2026, buying an estimated $371K and bringing the position to 7,960 shares worth $1.19M. The position accounts for 0.21% of the portfolio, ranked #63.

Abel Hall LLC first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Abel Hall LLC held 7,960 shares of Guardant Health worth $1.19M as of Q2 2026.
  • Abel Hall LLC bought 3,409 Guardant Health shares in Q2 2026, an estimated $371K.
  • Guardant Health made up 0.21% of Abel Hall LLC's portfolio in Q2 2026, its #63 holding.
  • Abel Hall LLC first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.